The company also reported a 184 percent sales increase for the fourth quarter of 2010 as compared with the fourth quarter of 2009. John A. Redmond, CEO of RSB Spine, attributes the company’s success to a unique product line and the execution of master distributor Paradigm BioDevices.
The company’s InterPlate platform has gained market acceptance over the past year, which contributes to the company’s success as well.
Read the RSB Spine release on the 4Q 2010 financial report.
Read other coverage on RSB Spine:
– RSB Spine’s InterPlate L-Ti Receives Clearance as an Anterior Lumbar Plate
– RSB Spine Sales Increase 38% for 2009
– FDA Approves RSB Spine’s InterPlate C-Ti as an Anterior Cervical Plate
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.